ADVERTISEMENT

This Consultant Thinks Sun Pharma’s Halol Unit Can Be Cleared Without Re-Inspection

Sun Pharma’s Halol unit can be cleared without any re-inspection, said Estima Pharma Solutions.

Employees enter the Sun Pharmaceutical Industries Ltd. corporate office in the Andheri suburb of Mumbai, India. (Photographer: Amit Madheshiya/Bloomberg).
Employees enter the Sun Pharmaceutical Industries Ltd. corporate office in the Andheri suburb of Mumbai, India. (Photographer: Amit Madheshiya/Bloomberg).

The Halol, Gujarat unit of Sun Pharmaceuticals Ltd. can be cleared without any re-inspection as the observations received from the U.S. Food and Drug Administrator are minor, said Gurudatta GG, chief executive officer at consulting firm Estima Pharma Solutions.

If the plant is cleared, India’s largest drugmaker will venture into manufacturing new products and also ease the production of older ones, Gurudatta told BloombergQuint in an interview.

Watch the full conversation here: